Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Levice – page 6

155 clinical trials in Levice, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Levice at a glance
155
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

155 trials in Levice

Open in trial search

Arteriosclerosis

Not recruiting

Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Colitis ulcerative

Not recruiting

Study on BI 3032950 for Patients with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:BI 3032950
  • Sponsor:Boehringer Ingelheim International GmbH

Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Coeliac disease

Not recruiting

Study on the Effects of Amlitelimab for Adults with Non-Responsive Celiac Disease

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Crohn's disease

Not recruiting

Study on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn's Disease

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Etrasimod Arginine
  • Sponsor:Arena Pharmaceuticals Inc.

Colitis ulcerative

Not recruiting

Study on the Effects of Tamuzimod in Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Tamuzimod Acetate
  • Sponsor:Oppilan Pharma Limited

Hypertriglyceridaemia

Not recruiting

Study of Plozasiran for Adults with Severe Hypertriglyceridemia

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Colitis ulcerative

Not recruiting

Study on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Etrasimod Arginine
  • Sponsor:Arena Pharmaceuticals Inc.

Hypertriglyceridaemia

Not recruiting

Study to Evaluate Plozasiran for Adults with High Triglycerides

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Crohn's disease

Not recruiting

Study of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn's Disease

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Ozanimod
  • Sponsor:Celgene International II S.a.r.l.

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Crohn's disease

Not recruiting

Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Ozanimod
  • Sponsor:Celgene International II S.a.r.l.

Other cities in Slovakia

The busiest research cities in the country

All 88 cities in Slovakia

Clinical research in Levice

What the registry says about research in the country

01 Cardiovascular Diseases

In Levice, cardiovascular disease research focuses on preventing serious events such as stroke, heart attack, and other vascular complications. These studies are designed to assess new options for stroke prevention, atherosclerotic cardiovascular disease, and related risk reduction.

  • Acute ischemic stroke and high-risk transient ischemic attack
  • Atrial fibrillation with prevention of stroke or systemic embolism
  • Atherosclerotic cardiovascular disease and systemic inflammation
  • High LDL cholesterol and broader cardiovascular risk

The trials are mainly evaluating whether new treatments can improve protection against major cardiovascular events and support better long-term outcomes.

02 Respiratory Tract Diseases

A large share of the clinical research in Levice is centered on asthma and chronic obstructive pulmonary disease. These studies explore ways to improve breathing control, reduce flare-ups, and slow the decline in lung function in people with persistent respiratory symptoms.

  • Moderate to severe asthma and uncontrolled asthma
  • Chronic obstructive pulmonary disease and chronic bronchitis
  • Asthma with frequent exacerbations
  • Severe COPD outcomes and lung function decline

Overall, the research is aimed at testing new therapies and combination treatments that may help people breathe more easily and stay stable for longer.

03 Nutritional and Metabolic Diseases

Clinical trials in this area examine overweight, obesity, type 2 diabetes, and hyperlipidemia. The goal is to better understand treatment approaches that may support weight reduction and improve metabolic health.

  • Overweight or obesity with type 2 diabetes
  • Hyperlipidemia and elevated cardiovascular risk
  • Weight management in people with metabolic disease
  • Metabolic risk linked to heart and vascular complications

These studies are mainly testing whether newer therapies can improve key health markers and reduce the burden of metabolic disease.

04 Skin and Connective Tissue Diseases

Research in skin and connective tissue diseases is represented by studies on chronic spontaneous urticaria. The main purpose is to evaluate treatments that may improve symptom control and provide longer-lasting relief for people with persistent allergic skin disease.

  • Chronic spontaneous urticaria
  • Long-term symptom control
  • Relapse prevention and treatment durability

This area adds a focused immunology component to the clinical trial landscape in Levice.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.